MEMBRANOUS NEPHROPATHY - PLA2R INDUCED

Clinical trials for MEMBRANOUS NEPHROPATHY - PLA2R INDUCED explained in plain language.

Never miss a new study

Get alerted when new MEMBRANOUS NEPHROPATHY - PLA2R INDUCED trials appear

Sign up with your email to follow new studies for MEMBRANOUS NEPHROPATHY - PLA2R INDUCED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New drug tested for rapid control of damaging kidney disease

Disease control Recruiting now

This study is testing a drug called obinutuzumab to see how quickly it can lower harmful antibodies in adults with a serious autoimmune kidney disease called membranous nephropathy. It will involve 20 patients who still have high protein in their urine despite standard care. The …

Matched conditions: MEMBRANOUS NEPHROPATHY - PLA2R INDUCED

Phase: PHASE2, PHASE3 • Sponsor: Radboud University Medical Center • Aim: Disease control

Last updated Mar 30, 2026 14:27 UTC

MEMBRANOUS NEPHROPATHY - PLA2R INDUCED

Get alerted when new MEMBRANOUS NEPHROPATHY - PLA2R INDUCED trials appear

New drug tested for rapid control of damaging kidney disease